ASCENDIA PHARMACEUTICAL SOLUTIONS Trademark

Trademark Overview

On Thursday, September 2, 2021, a trademark application was filed for ASCENDIA PHARMACEUTICAL SOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the ASCENDIA PHARMACEUTICAL SOLUTIONS trademark a serial number of 97008685. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, May 30, 2025. This trademark is owned by Ascendia Pharmaceuticals, Inc.. The ASCENDIA PHARMACEUTICAL SOLUTIONS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development of pharmaceuticals designed via physical means to be released into the body over a period of time
ascendia pharmaceutical solutions

General Information

Serial Number97008685
Word MarkASCENDIA PHARMACEUTICAL SOLUTIONS
Filing DateThursday, September 2, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, May 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

NOT AVAILABLE"PHARMACEUTICAL SOLUTIONS"
Goods and Servicesresearch and development of pharmaceuticals designed via physical means to be released into the body over a period of time

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code042
First Use Anywhere DateFriday, December 6, 2024
First Use In Commerce DateFriday, December 6, 2024

Trademark Owner History

Party NameAscendia Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902
Party NameAscendia Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Tuesday, June 7, 2022ASSIGNED TO EXAMINER
Monday, September 6, 2021NEW APPLICATION ENTERED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 8, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 8, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, June 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, June 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Monday, March 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 6, 2023SOU EXTENSION 1 FILED
Monday, March 6, 2023SOU EXTENSION 1 GRANTED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 12, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 12, 2024SOU EXTENSION 3 GRANTED
Monday, February 12, 2024SOU EXTENSION 3 FILED
Tuesday, February 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 4 FILED
Wednesday, August 14, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 5, 2025USE AMENDMENT FILED
Thursday, March 6, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, May 29, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, May 30, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 23, 2023SOU EXTENSION 2 FILED
Wednesday, August 23, 2023SOU EXTENSION 2 GRANTED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

solutions pharmaceutical ascendia body over period time released means development pharmaceuticals designed physical